MannKind Study to assess safety, efficacy and treatment experience of starting inhaled insulin in youth aged 10 to
Copyright MatchingDonors.com © 2026 All rights reserved.
Daily Diabetes News is published by MatchingDonors.com.
Tag:
T1D
-
-
Type 1
MannKind Announces First Patient Enrolled in INHALE-1ST Pediatric Study Evaluating Afrezza® for Youth with Newly-Diagnosed Type 1 Diabetes (T1D)
by MannKindby MannKind -
Type 1
Breakthrough T1D Celebrates Generosity of Land O’Frost and Announces National Partnership to Support Type 1 Diabetes Research
by News Sourceby News SourceNEW YORK, Feb. 9, 2026 /PRNewswire/ — Breakthrough T1D, formerly JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, is proud to announce Land O’Frost, a third-generation, …
-
-
Type 1
Breakthrough T1DCongress Passes Bipartisan Extension of the Special Diabetes Program, Securing Critical T1D Research FundingCongress has passed bipartisan legislation to extend and strengthen the Special Diabetes Program (SDP), a cornerstone of Federal investment….3 hours ago
by Anton Beckerby Anton BeckerBreakthrough T1DCongress Passes Bipartisan Extension of the Special Diabetes Program, Securing Critical T1D Research FundingCongress has passed bipartisan legislation to extend and strengthen the Special Diabetes Program (SDP), a cornerstone …
-
Type 1
Breakthrough T1D“Do good, feel good”: Alecia Wesner’s T1D clinical trial journeyAs a Participant Advisory Council member, Alecia Wesner shares her lived experience with type 1 diabetes and clinical trials..7 hours ago
Breakthrough T1D“Do good, feel good”: Alecia Wesner’s T1D clinical trial journeyAs a Participant Advisory Council member, Alecia Wesner shares her lived experience with type 1 diabetes and clinical trials..7 hours …
-
Type 1
Breakthrough T1D Expresses Gratitude to Long-Time Partner Ford for Donating the Auction Proceeds of the First Mustang Dark Horse SC to Type 1 Diabetes Research
NEW YORK, Jan. 29, 2026 /PRNewswire/ — Breakthrough T1D, formerly JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, is thrilled to recognize the generosity of Ford …
-
Type 1
The T1D Fund Strengthens Expertise With Appointment of Biotech Industry Veteran and Cell Therapy Expert Teresa Foy, Ph.D., to Advance Next Generation of Type 1 Diabetes (“T1D”) Therapies
by The T1D Fundby The T1D FundFormer Bristol Myers Squibb and Celgene executive to strengthen the Fund’s impact strategy and fuel transformative investments across innovative modalities BOSTON, Jan. 21, 2026 /PRNewswire/ — The T1D Fund: A Breakthrough …
-
-
Type 1
Breakthrough T1D Awards $1.5 Million Grant to Blue Circle Health to Expand Access to Care for Underserved Adults with Type 1 Diabetes
Grant will strengthen insurance and Medicaid navigation and continuity of care for adults living with T1D NEW YORK, Jan. 15, 2026 /PRNewswire/ — Breakthrough T1D, the leading global type 1 …